Literature DB >> 24628987

A prospective and randomized comparison of limited versus extensive atrial substrate modification after circumferential pulmonary vein isolation in nonparoxysmal atrial fibrillation.

Yenn-Jiang Lin1,2, Shih-Lin Chang1,2, Li-Wei Lo1,2, Yu-Feng Hu1,2, Eric Chong1,2, Tze-Fan Chao1,2, Fa-Po Chung1, Jonan Liao1, Cheng-Hung Li3, Hsuan-Ming Tsao4, Tsair Kao5, Yun-Yu Chen1, Jin-Long Huang2,3, Shih-Ann Chen1,2.   

Abstract

INTRODUCTION: The optimal substrate ablation approach in patients with persistent atrial fibrillation (Per AF) remains unclear. This was a prospective randomized study comparing the efficacy of limited (continuous complex fractionated atrial electrogram, CFAE: <60 milliseconds) versus extensive (continuous CFAE plus variable CFAE: <120 milliseconds) atrial substrate modification in Per AF patients. METHODS AND
RESULTS: We enrolled 120 Per AF patients in the study, and 30 patients with AF termination after pulmonary vein isolation (PVI) were excluded. In the remaining 90 patients, 45 were treated with limited approach (Group 1) and 45 with an extensive approach (Group 2). The end point of the study was the incidence of an atrial arrhythmia recurrence postblanking period. The patients were followed up for 15 months with 3-month clinical reviews, electrograms (ECGs), Holter recordings, and echocardiographic monitoring. Procedural AF termination and the single procedural efficacy were statistically comparable between the 2 groups (48.9% vs. 63.4% in Groups 1 and 2, respectively, P = 0.289). During the follow-up, patients who received limited ablation had a lower incidence of recurrent AFL (P = 0.04), and better reverse remodeling of the left atrium (LA, P = 0.04). After 2 procedures, the freedom from any atrial arrhythmia was better in Group 2 (62.2% vs. 87.8%, P = 0.009). Those with longstanding AF and a larger baseline LA size responded better to the extensive ablation.
CONCLUSIONS: In the Per AF patients who failed to achieve AF termination after PVI alone, a specific atrial substrate modification approach targeting only continuous CFAEs could be considered as an initial ablation strategy.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  atrial fibrillation; atrial substrate; catheter ablation; complex fractionated atrial electrograms; electrogram; pulmonary vein isolation

Mesh:

Year:  2014        PMID: 24628987     DOI: 10.1111/jce.12407

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  10 in total

Review 1.  Beyond Pulmonary Vein Isolation: the Role of Additional Sites in Catheter Ablation of Atrial Fibrillation.

Authors:  Li-Wei Lo; Yenn-Jiang Lin; Shih-Lin Chang; Yu-Feng Hu; Fa-Po Chung; Shih-Ann Chen
Journal:  Curr Cardiol Rep       Date:  2017-08-09       Impact factor: 2.931

2.  Pharmacological Tests in Atrial Fibrillation Ablation.

Authors:  Jean-Baptiste Gourraud; Jason G Andrade; Laurent Macle; Blandine Mondésert
Journal:  Arrhythm Electrophysiol Rev       Date:  2016

Review 3.  Is pulmonary vein isolation still the cornerstone in atrial fibrillation ablation?

Authors:  T Jared Bunch; Michael J Cutler
Journal:  J Thorac Dis       Date:  2015-02       Impact factor: 2.895

Review 4.  Mapping Atrial Fibrillation: 2015 Update.

Authors:  Chirag R Barbhayia; Saurabh Kumar; Gregory F Michaud
Journal:  J Atr Fibrillation       Date:  2015-12-31

Review 5.  Surgical perspectives in the management of atrial fibrillation.

Authors:  Katerina Kyprianou; Agamemnon Pericleous; Antonio Stavrou; Inetzi A Dimitrakaki; Dimitrios Challoumas; Georgios Dimitrakakis
Journal:  World J Cardiol       Date:  2016-01-26

6.  The presence of left atrial posterior wall fibrillation despite restoration of sinus rhythm after posterior box ablation.

Authors:  Khalid Abozguia; Michael J Cutler; Ohad Ziv
Journal:  HeartRhythm Case Rep       Date:  2015-08-28

7.  Left Atrial Posterior Wall Thrombus After Posterior Wall Ablation.

Authors:  Shourjo Chakravorty; Sangeeta Shah; Michael L Bernard
Journal:  Ochsner J       Date:  2020

8.  Impact of electrophysiological and pharmacological noninducibility following pulmonary vein isolation in patients with paroxysmal and persistent atrial fibrillation.

Authors:  Takayuki Otsuka; Koichi Sagara; Takuto Arita; Naoharu Yagi; Shinya Suzuki; Takanori Ikeda; Takeshi Yamashita
Journal:  J Arrhythm       Date:  2018-09-10

9.  Is ablation to atrial fibrillation termination of persistent atrial fibrillation the end point?: A systematic review and meta-analysis.

Authors:  Fanghui Li; Xiang Tu; Dongze Li; Ying Jiang; Yisong Cheng; Yu Jia; Xinyu Zhang; Hua Fu; Hongde Hu; Jian Jiang; Rui Zeng
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

10.  Clinical Utility of Intravenous Nifekalant Injection during Radiofrequency catheter Ablation for Persistent Atrial Fibrillation.

Authors:  Tetsuma Kawaji; Satoshi Shizuta; Shintaro Yamagami; Takanori Aizawa; Akihiro Komasa; Takashi Yoshizawa; Masashi Kato; Takafumi Yokomatsu; Shinji Miki; Koh Ono; Takeshi Kimura
Journal:  J Atr Fibrillation       Date:  2018-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.